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Executive Summary 
INTRODUCTION 
The progesterone vaginal ring (PVR) is a ring-shaped device used by postpartum women to extend the 
contraceptive effectiveness of lactational amenorrhea. The ring is inserted in the vagina 6–9 weeks 
postpartum (for study purposes; 30–90 days in normal service delivery settings) for continuous use for 
up to 3 months and replaced with a new one if breastfeeding is continued and extended contraception is 
desired. The ring diffuses a continuous flow of low-dose progesterone through the vaginal walls, which 
enters the bloodstream and regulates the woman’s fertility by suppressing ovulation. Previous studies 
have shown that contraceptive vaginal rings are safe, effective, and well accepted in varied cultural 
settings. However, the extent to which the ring is acceptable in the sub-Saharan African context is 
unknown, especially since vaginal rings are a new technology and use of vaginal products such as 
tampons is limited in the region.  
STUDY OBJECTIVES 
This study examined the acceptability of PVR in Kenya as part of a larger project that was also conducted 
in Nigeria and Senegal. The specific objectives of the study were to assess the factors influencing the 
acceptability of the method among clients, their spouses, providers, community members, and those who 
were counseled on but did not choose the method. 
METHODS 
The study involved prospective follow-up of participants who chose the ring (PVR users) for up to 6 
months or two ring cycles, interviews with providers at baseline and endline, as well as cross-sectional 
interviews with women who were counseled on but did not choose the ring (PVR nonusers) and key 
stakeholders. A total of 60 PVR users were enrolled for follow-up, another 5 PVR users were enrolled for 
in-depth interviews, and 58 nonusers were interviewed upon exit. Data collection involved completion of 
case record forms by providers during enrollment; quantitative exit interviews with clients during 
enrollment, at 3 months, and at 6 months following ring use or at discontinuation; quantitative exit 
interviews with PVR nonusers; in-depth interviews with a subset of PVR users at 1 month, 3 months, and 
6 months following ring use; in-depth interviews with spouses of PVR users at endline; focus group 
discussions with community leaders at endline; and self-administered interviews with providers at 
baseline and endline. Analysis of the quantitative data entailed simple frequencies. Directed content 
analysis techniques were employed for analyzing the qualitative data.  
KEY FINDINGS 
 
 Acceptability of the ring: The majority of participants who completed the two ring cycles indicated that they 
would use the ring in the future (92%), their partners or family members would support future use (87%), 
they would recommend or had already recommended the ring to their friends or family members (92% and 
73%, respectively), and that they were willing to pay for the method (77%). In addition, some participants 
were encouraged by their spouses to use the ring. There were also remarkable positive changes between 
baseline and follow-up in the perceptions of participants and providers about the ring.  
 
 Reasons for choosing the ring: The most commonly cited reason for choosing the ring among users was 
that the method is user-controlled (49%). The second major reason was perceived fewer side effects 
(46%). In addition, some participants chose the ring just to try a new method (14%), while others chose it 
because their preferred method was not available at the time of the visit (5%). Most users also found the 
ring easy to insert, remove, and reinsert. 
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 Client profile: The majority of women who chose the ring were aged 20–29 years (77%), had at least 
secondary level education (60%), and resided in urban or peri-urban areas (67%). In addition, the majority 
of PVR users had given birth to at least 2 children (54%) and wanted to space the next birth by at least 4 
years (71%).  
 
 Prior use of family planning: Slightly more than one-third of PVR users (37%) were new family planning 
users. Among women who had previously used a method, the methods ever used were pills (55%), 
injectables (45%), implants (10%), emergency contraceptive pills (8%), male condoms (5%), intrauterine 
contraceptive devices—IUDs (5%), and female condoms (3%).  
 
 Subsequent method choice: Those who completed two ring cycles were more likely to switch to implants 
and intrauterine contraceptive devices (IUDs) compared with those who terminated use (57% versus 17% 
for implants and 25% versus 6% for IUDs). Switching to long-term methods was also consistent with the 
finding that most users desired to space the next pregnancy by at least 4 years.  
 
 Discontinuation of use: Participants who discontinued use of the ring did so for various reasons including 
ring expulsion, experiencing side effects, nonadherence to use instructions, opposition by mother-in-law, 
husband/partner discomfort during sex, misconception about the method, and experiencing a serious 
adverse event.    
 
IMPLICATIONS 
 
 
 The findings of the study indicate that the ring was acceptable to most clients and key stakeholders. In 
addition, several positive attributes of the ring that were mentioned by participants are likely to increase 
uptake of the method. 
 
 The profile of PVR users suggests that young, educated, urban or peri-urban dwellers are likely to be the 
first acceptors of the method if it is introduced into the country before it diffuses to other segments of the 
population. 
 
 The reasons given for choosing the ring and the fact that about one-third of the participants were new 
users suggest that the method is likely to expand contraceptive choice during the postpartum period, 
enhance women’s autonomy in contraceptive use, and sustain or contribute to an increased contraceptive 
prevalence rate in the country. 
 
 The finding that those who completed the two ring cycles mostly switched to long-term methods at the end 
of the study and that most users desired longer birth spacing suggests that programs delivering the ring 
need to consider mechanisms for bridging users to long-term methods.     
 
 Given that the ring is a user-controlled method, service-delivery programs should consider ways of 
ensuring that clients obtain information on correct use, including proper insertion and adherence to use 
instructions, such as not leaving the ring out for long. Proper insertion and adhering to use instructions 
are, in turn, likely to reduce instances of ring expulsion and discontinuation.  
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Introduction 
The progesterone vaginal ring (PVR) is used to extend the contraceptive effectiveness of lactational 
amenorrhea among breastfeeding women. The ring is inserted in the vagina 6–9 weeks postpartum for study 
purposes (30–90 days in normal service delivery conditions) for continuous use for up to 3 months and 
replaced with a new one if breastfeeding is continued and extended contraception is desired. Women can use 
four rings successively for up to one year postpartum. PVR functions by diffusing a continuous flow of 
progesterone through the vaginal walls—approximately 10 mg per day—which then enters the bloodstream and 
regulates the woman’s fertility by suppressing ovulation. Progesterone also thickens the cervical mucus 
thereby inhibiting sperm penetration into the uterus. Clinical trials have demonstrated that PVR is an effective 
contraceptive method (Sivin et al. 1997; Massai et al. 1999). The method was first registered in Chile and Peru 
in 1998 for use by postpartum women but has since been expanded to other Latin American countries, 
including Bolivia, the Dominican Republic, Ecuador, and Guatemala (Reproductive Health Supplies Coalition 
[RHSC] 2011).   
 
Previous studies conducted by the Population Council have demonstrated that vaginal rings are well accepted 
in settings as culturally diverse as Australia, Egypt, Latin America, Singapore, and the United States (RHSC 
2011). However, the extent to which PVR is acceptable in the sub-Saharan African context is unknown, 
especially since vaginal rings are a new technology in this setting and use of vaginal products such as tampons 
is limited in the region. An understanding of the acceptability of the ring is important for informing the 
introduction of the method in the region. Sub-Saharan Africa in particular presents an opportunity for 
expanding the use of the method given relatively long breastfeeding durations; high unmet need for 
contraception, especially during the postpartum period; and the potential for multiple channels of introducing 
the method to potential users, including public and private clinics as well as private pharmacies and 
community distribution systems (Haggerty and Rutstein 1999; Westoff 2012). Moreover, since the use of PVR 
is predicated upon women breastfeeding at least four times a day, it provides an opportunity to promote 
breastfeeding while ensuring contraceptive protection, thereby benefiting both mothers and their infants. 
 
To understand the extent of acceptability of the method in the region, the Population Council conducted 
acceptability studies in Kenya, Nigeria, and Senegal. This report presents findings from the study in Kenya. The 
study was one component of a number of activities aimed at informing the introduction of the method in the 
country. Other activities included global and national consultations with key stakeholders, assessments and 
documentation of the regulatory and procurement frameworks, and market segmentation and demand 
analysis.  
 
STUDY OBJECTIVES 
 
This study examined the acceptability of PVR in Kenya as part of a larger project that was also conducted in 
Nigeria and Senegal. The specific objective of the study was to assess the factors influencing the acceptability 
of the method among clients, their spouses, providers, community members, and women who were counseled 
on but did not choose the method. 
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STUDY CONTEXT 
 
Estimates from the Kenya Demographic and Health Surveys (KDHS) show that the contraceptive prevalence 
rate (proportion of currently married women using any method of contraception) more than doubled over a 
period of a quarter century from 27% in 1989 to 58% in 2014 (National Council for Population and 
Development [NCPD] and Institute for Resource Development/Macro Systems 1989; Kenya National Bureau of 
Statistics [KNBS] et al. 2015). Over the same period, the use of modern methods increased almost three-fold 
from 18% in 1989 to 53% in 2014 (NCPD and Institute for Resource Development/Macro Systems 1989; 
KNBS et al. 2015). In spite of the improvements, contraceptive use remained lower than the national average 
in rural areas. Contraceptive use was also lowest among young women aged 15–19 years, those with no 
education, and those from the poorest households. In addition, estimates from the 2008–09 KDHS showed 
that only 25% of postpartum women were using a family planning method compared with the national 
contraceptive prevalence rate (CPR) of 46% at that time (Gebreselassie et al. 2008; KNBS and ICF Macro 
2010).  
 
Over time, unmet need for contraception declined by almost half from 35% in 1993 to 18% in 2014 (NCPD and 
Institute for Resource Development/Macro Systems 1989; KNBS et al. 2015). However, there was only a slight 
decline in unmet need between 1998 and 2008–09 from 28% to 26% (NCPD et al. 1999; KNBS and ICF 
Macro 2010). In addition, unmet need for contraception remained higher than the national average in rural 
areas. Unmet need also remained highest among the youngest age groups (15–24 years), those with low 
levels of education (no education and primary incomplete), and those from the poorest households (NCPD et 
al. 1999; CBS et al. 2004; KNBS and ICF Macro 2010; KNBS et al. 2015). Estimates from the 2008–09 KDHS 
further showed that unmet need was more than twice as high among postpartum women compared with those 
in the general population (68% and 26%, respectively) (Gebreselassie et al. 2008; KNBS and ICF Macro 2010).  
 
Trends in contraceptive method mix show that over time, the use of modern methods has been dominated by 
injectables—from 19% of all modern methods in 1989 to 55% in 2008–09 (NCPD and Institute for Resource 
Development/Macro Systems 1989; KNBS and ICF Macro 2010). The trend has been accompanied by 
declining use of pills (from 26% to 18%), IUDs (from 21% to 5%), and female sterilization (from 29% to 12%) 
(NCPD and Institute for Resource Development/Macro Systems 1989; KNBS and ICF Macro 2010). Moreover, 
the postpartum period is characterized by a limited range of available family planning methods that include the 
lactational amenorrhea method (LAM), IUD, sterilization, progestin-only pills, injectables, and condoms. The 
Ministry of Health (MOH) therefore recognizes the need for family planning information and services during the 
postpartum period as an integral component of maternal and neonatal care services (DRH/MOPHS 2010). 
Programs to strengthen family planning service provision during the postpartum period have to date been 
implemented on a pilot basis in selected districts with limited stakeholder involvement to ensure sustainability 
(Mwangi et al. 2008; Chebet and Jahonga 2011). These programs have, however, demonstrated substantial 
improvements in the uptake of family planning in the postpartum period (Mwangi et al. 2008; Chebet and 
Jahonga 2011). 
 
Regarding breastfeeding practices, estimates from the 2008–09 KDHS showed that nearly all children under 
five years of age (97%) were ever breastfed (KNBS and ICF Macro 2010). Mothers initiated breastfeeding 
within one hour of birth for 58% and within one day of birth for 86% of the children ever breastfed (KNBS and 
ICF Macro 2010). The median duration for any breastfeeding was 21 months, while the median duration for 
exclusive breastfeeding was less than one month (KNBS and ICF Macro 2010). Ninety-three percent of 
children under the age of 6 months were breastfed 6 or more times within a 24-hour period, while 32% of 
children under the age of 6 months are exclusively breastfed (KNBS and ICF Macro 2010). In September 
2012, parliament passed a law aimed at promoting exclusive breastfeeding for the first 6 months and 
continuous breastfeeding after the introduction of other foods up to a period of 24 months. The law was, 
however, criticized for seeking to regulate the marketing, promotion, distribution, and sale of breast milk 
substitutes rather than promote exclusive breastfeeding (Maina 2012). The government has also formulated 
several policies aimed at protecting, promoting, and supporting optimal infant feeding practices (Republic of 
Kenya 2012).  
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Methods 
STUDY DESIGN 
 
The study used both prospective and cross-sectional designs. The prospective component involved enrolling 
and following up participants over a period of 6 months (2 ring cycles) or up to discontinuation of use of the 
ring. Participants were interviewed at the time of recruitment (baseline), at 3 months and 6 months if they 
completed the two ring cycles, or at the time they left the study if they discontinued use. Providers who were 
trained on the provision of the method were also interviewed at baseline and endline. The cross-sectional 
component involved interviews with women who were counseled on the ring but did not choose it at baseline 
as well as community opinion leaders and husbands of PVR users at endline.    
STUDY SETTING 
 
The study was conducted in six public health facilities (two health centers and four hospitals) in three counties 
in Kenya (Kiambu, Muranga, and Nairobi). The sites were selected in conjunction with the MOH/Kenya based 
on onsite availability of postpartum family planning services, a reasonable caseload of women seeking family 
planning before nine weeks postpartum, no other new contraceptive being introduced, the feasibility of 
following up participants, being project sites of the Urban Reproductive Health Initiative (URHI), ability to meet 
Population Council research standards and global Good Clinical Practice (GCP) guidelines, as well as the ability 
to absorb the workload necessitated by the study such as documentation and client follow-up. Three of the 
sites were located in rural areas, two in urban areas and one in a peri-urban setting. Throughout this report, 
the term “site” or “study site” is used to refer to the health facilities where the study was conducted. 
STUDY PROCEDURES 
 
The study was preceded by a mapping exercise that involved consultative meetings with key government, 
regulatory, and development agencies; social marketing organizations; research institutions; 
manufacturers/distributors of health commodities; community/advocacy groups; institutions involving 
public/private partnerships; and other organizations providing family planning services in the country. The 
purpose of the exercise was to determine the perspectives of the stakeholders regarding the method and the 
acceptability study. The next step involved obtaining the ethical, research, and regulatory approvals necessary 
for importation of rings into the country and for conducting the study. Ethical clearance for the study was 
granted by the Institutional Review Board (IRB) of the Population Council (Protocol number 562) and the Ethics 
and Research Committee (ERC) of Kenyatta National Hospital/University of Nairobi (Protocol number 
P625/11/2012). The National Commission for Science, Technology and Innovation (NACOSTI) granted the 
research permit for the study (Reference number NCST/5/002/R/683), while the Pharmacy and Poisons 
Board (PPB) granted the regulatory approval (Reference number PPB/ECCT/13/03/01/2013(93) and import 
license (Number T/13/6357P). The import license allowed for importation of a limited quantity of rings for 
research purposes only. 
 
A total of 35 service providers from the six selected sites and four health managers/supervisors were trained 
on the provision of PVR. The training was organized in two separate sessions and involved approximately three 
providers from each health facility to avoid interfering with normal service delivery that could occur if all service 
providers were trained at the same time. The providers were trained on PVR and how it works, the counseling 
process, enrollment procedures (inclusion and exclusion criteria), good clinical practice, and completion of the 
relevant documentation during recruitment. Six research assistants who had social science backgrounds were 
also trained to conduct interviews with clients upon exit and during follow-up. The research assistants were 
trained on the method and how it works, study design, interviewing skills, and ethical considerations in the 
study. All research assistants undertook online courses on ethics and obtained certifications before being 
assigned to the facilities. They were stationed at the facilities throughout the duration of the study.   
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Recruitment of participants into the study started in November 2013 following the training of providers 
and research assistants and ended in early February 2014 when the target was realized. A total of 58 
clients aged 18–35 years were targeted for enrollment for quantitative interviews. A similar sample size 
was targeted in each of the other two countries included in the study (Nigeria and Senegal). The sample 
size was, however, powered to detect significant differences in all the three countries combined rather 
than at the individual country level. Another five participants were targeted for enrollment for in-depth 
interviews (IDIs) after one month of using the ring, at three months, and at six months. The study further 
targeted 58 participants who were counseled on the ring but did not choose the method, in order to 
understand the reasons guiding their choices. 
 
The recruitment process entailed providers counseling postpartum clients seeking family planning 
services on all available methods including PVR so that all clients had a choice of methods. Clients who 
were identified from other units, such as immunization and growth monitoring, were encouraged to visit 
the family planning unit if they needed contraceptive services. Clients who chose the ring during 
counseling were directed to the research assistant who completed the written informed consent process 
before providers could dispense the method. Clients were informed about the study procedures including 
the requirement to undergo pregnancy and HIV tests as part of inclusion and exclusion criteria as well as 
the need for follow-up. Those clients who granted written informed consent were then directed back to 
the provider for medical examination. Clients who qualified for the ring after satisfying the inclusion and 
exclusion criteria were then specifically counseled on the method and shown how to use it. 
 
Providers were instructed to show enrolled participants how to insert and remove the ring, and to ensure 
that they left the facility when the ring was properly inserted. In particular, providers were trained to insert 
the ring, ask participants to remove it and reinsert themselves, and confirm that they were not feeling it 
after reinsertion before leaving the facility. Clients who did not grant written informed consent and those 
who did not satisfy the inclusion and exclusion criteria after screening were offered other methods, even 
if they had initially chosen the ring. Clients who were given the ring were then interviewed by the research 
assistants upon exit. They were advised to return to the facility after three months with the used ring to 
obtain another one, or at any time in case of concerns regarding the use of the ring. During exit 
interviews, the research assistants obtained contact information to follow up with the clients in the event 
that they did not return to the study site.  
 
Given that the ring was being introduced in the context of a study, there were elaborate inclusion and 
exclusion criteria as outlined in Appendix A1. In addition, the study monitor conducted regular site visits 
to ensure compliance with study procedures, good clinical practice, ethical conduct of the study, and 
recordings of adverse and serious adverse events, if any. Participants were also instructed to report all 
side effects including adverse or serious adverse events (AEs or SAEs), while providers were trained to 
ask and record all side effects that women reported. 
DATA COLLECTION 
 
The first component of data collection involved information captured by service providers through case record 
forms. These included forms for screening for eligibility, medical examination, concomitant prior medication, 
unscheduled visits, follow-up visits, missed visits, unscheduled calls, pregnancy outcomes (in case a 
participant became pregnant when using the ring), adverse events, serious adverse events, and termination of 
participation in the study. Some of the forms, such as those for pregnancy outcomes, were not completed 
because no participant experienced a pregnancy when using the ring.    
 
The second component of data collection involved quantitative interviews with PVR users who were enrolled for 
prospective follow-up (Table 1). The participants were interviewed upon exit at baseline and at three and six 
months, or at study termination if they had discontinued. Baseline interviews captured information on 
background characteristics (such as age, type of place of residence, education level, marital status, 
occupation, and religious affiliation), reproductive history and preferences, contraceptive use, perceptions 
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about the quality of care received during the visit, as well as perceptions about the PVR and other vaginally 
inserted products. Follow-up interviews captured information on the status of ring use, ease of use, 
experiences of ring expulsion, general health status during ring use, sexual activity during ring use, and the 
level of satisfaction with the method. Quantitative interviews were also conducted with consenting clients who 
were counseled on the ring but did not choose to adopt it to capture information on their characteristics, 
choice of method, and reasons guiding their choices. 
 
The third component of data collection involved qualitative interviews with various stakeholders. In particular, 
in-depth interviews (IDIs) were conducted with additional women who were enrolled in the study (Table 1). The 
interviews were conducted at one, three, and six months following ring use. The interviews explored their 
experiences using the ring and their perceptions about the method. In-depth interviews were also conducted 
with three husbands of PVR users who informed their spouses that they were using the ring to determine their 
perceptions about the method. In addition, three focus group discussions (FGDs) were held with community 
stakeholders including religious leaders, women leaders, and youth leaders to determine their perceptions 
about the method. All qualitative interviews and discussions were audiotaped and transcribed. 
 
Service providers also completed self-administered questionnaires at the end of training (at baseline) and at 
the end of participant follow-up (at endline). Information was collected on their background characteristics 
(such as age, sex, and technical qualification), knowledge and practices regarding postpartum family planning 
including PVR, perceptions about the method, and at endline, experiences dispensing the method to study 
participants.   
DATA MANAGEMENT AND ANALYSIS 
 
Exit interviews with PVR users at baseline and endline were conducted using personal digital assistants (PDAs). 
The data were then downloaded into computers at the Population Council office in Nairobi every Friday evening 
during the study period. Data from case record forms and provider interviews were entered in EpiData in the 
Population Council office. The case record forms were photocopied and copies were left at the participating 
facilities together with participant files. All quantitative data were exported to Stata for cleaning and analysis. 
Analysis involved simple frequencies. 
 
Qualitative interviews were audiotaped, translated into English where necessary (for interviews that were 
conducted in Kiswahili), and transcribed in Word. A “directed approach” to content analysis (Hsieh and 
Shannon 2005) was employed for analyzing the interview transcripts: findings from the interviews’ major 
domains of inquiry were used as guidance for initial codes, and this level of coding was used to generate 
themes across all interviews with similar populations. These themes were taken to represent respondents’ 
general perceptions about the PVR and their experiences using it.  
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Results 
OVERALL STUDY METRICS 
A total of 83 women were screened for eligibility for participation in the study after choosing the ring during 
counseling (Table 1). Out of these, 78 were targeted for inclusion in quantitative interviews while 5 were 
targeted for inclusion in in-depth interviews. Since information was not collected on the number of women 
counseled on the method during the period of recruitment, it is not possible to determine the percent of 
women coming for postpartum family planning who chose the PVR. 
Sixty-five of the 83 women (78%) who were screened were 
found to be eligible to participate in the study and were 
therefore enrolled (Table 1). These comprised 60 of the 78 
women (77%) who were targeted for inclusion in the 
quantitative interviews and all women who were targeted 
for inclusion in the in-depth interviews. A total of 28 (43%) 
women who were enrolled in the study completed the two 
ring cycles (Table 1). Twenty-four of the women who 
completed the two ring cycles were included in the 
quantitative interviews, while 4 were included in the in-
depth interviews.  
 
DEMOGRAPHIC CHARACTERISTICS OF STUDY PARTICIPANTS 
More than three-quarters of the women who were enrolled for 
the quantitative interviews (77%) were aged 20–29 years (Table 
2). More than two-thirds (67%) of the women were from urban or 
peri-urban areas, 60% had a secondary and above level of 
education, while nearly all (98%) were either married or living 
with a man. Half of the women (50%) were not working, 
although partners of 93% of them were engaged in some kind of 
work with the majority (75%) of the partners being engaged in 
nonprofessional jobs such as manual/casual work and business 
or farming (Table 2).  
 
Further analysis showed that, as expected, there were variations 
in educational attainment by type of place of residence. In 
particular, only half (50%) of the rural residents had a secondary 
and above level of education, while about two-thirds of urban 
and peri-urban residents had that level of education (67% and 
64%, respectively). In contrast, the proportion of respondents 
that were not working was highest in the urban areas and lowest 
in peri-urban areas (56% in urban areas, 50% in rural areas, and 
45% in peri-urban areas). However, all women who lived in 
urban areas reported that their partners were engaged in some 
form of work, while the corresponding proportions for peri-urban 
and rural residents were 91% and 90%, respectively.      
  
TABLE 1  Enrollment and participation in 
the study 
Variable (n) 
Number of women screened 83 
Number of women enrolled 65 
Number of women who completed the 
study or used two rings 
 
28 
Number of PVR nonusers 
interviewed at baseline 
 
58 
Data source: CRFs and Baseline surveys. 
 
TABLE 2  Demographic characteristics of study 
participants 
Variable  (n)  Percent 
Age     
    18–19 
    20–24 
    25–29 
    30–35 
 4 
31 
15 
10 
 6.7 
51.7 
25.0 
16.7 
Place of residence 
    Urban 
    Peri-urban 
    Rural 
  
18 
22 
20 
  
30.0 
36.7 
33.3 
Education 
    Primary or lower 
    Secondary 
    College/university 
Marital status 
    Never married 
    Married 
    Cohabiting 
Respondent’s occupation 
    Not working 
    Nonprofessional 
    Professional 
Partner’s occupation 
    Not working 
    Nonprofessional 
    Professional 
  
24 
26 
10 
 
1 
58 
1 
 
30 
26 
4 
 
4 
45 
11 
  
40.0 
43.3 
16.7 
 
1.7 
96.7 
1.7 
 
50.0 
43.3 
6.7 
 
6.7 
75.0 
18.3 
Total  60  100.0 
Data source: Baseline dataset. 
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REPRODUCTIVE AND FAMILY PLANNING HISTORY 
 
Nearly half of the women (47%) who were enrolled in the study had given birth to one child and almost a 
similar proportion (48%) had one living child (Table 3). The majority (63%) reported that the pregnancy for the 
current child was intended, although most of the women (71%) desired to space the next pregnancy by at least 
four years. The majority (89%) reported discussing pregnancy spacing with their partners. In addition, 37% of 
the women were new family planning users (Table 3). 
 
Further analysis showed that the proportion 
of new users was higher among younger 
(below 25 years of age) women than older 
(25 years and above) women (49% and 
20%, respectively). Similarly, the proportion 
of new users was about five times higher 
among women who had given birth to one 
child than among those who had two or 
more children (64% and 13%, respectively). 
  
The proportion of new users was 
also highest in the urban areas 
(44%), followed by rural (35%) and 
peri-urban areas (31%). Similarly, 
the proportion of new users was 
more than twice as high among 
those with primary or lower levels of 
education (55%) compared with 
those with a secondary and above 
level of education (25%).   
Among women who had previously used a 
method, the pill was the most common 
method ever used (55%), followed by 
injectables (45%), implants (10%), and 
emergency pills (8%) (Figure 1). As already 
noted, the contraceptive method mix in Kenya has been characterized by a declining use of pills, intrauterine 
contraceptive devices (IUDs), and female sterilization, and an increasing use of injectables. 
  
TABLE 3  Reproductive history and family planning use  
Variable  (n)  Percent 
Children ever born     
   1 
   2  
   3 or more 
 28 
20 
12 
 46.7 
33.7 
20.0 
Number of living children 
    1 
    2  
    3 or more     
  
29 
19 
12 
  
48.3 
31.7 
20.0 
Pregnancy was intended 
   Yes 
   No 
Preferred spacing of next birth 
    2–3 years 
    4–5 years 
    6 years or more 
Discussed pregnancy spacing with partner 
    Yes 
    No 
Prior use of a method 
    Ever used 
    Never used  
  
38 
22 
 
14 
23 
12 
 
50 
6 
 
38 
22 
  
63.3 
36.7 
 
28.6 
46.9 
24.5 
 
89.3 
10.7 
 
63.3 
36.7 
Data source: Baseline dataset (N=60). 
 
FIGURE 1 PREVIOUS METHOD USE 
 
Note: Question allowed for multiple responses. Data source: Baseline dataset (N=38). 
55.3
44.7
10.3
7.9
5.3
5.3
2.6
0 20 40 60
Pills
Injectables
Implants
Emergency pills
Male condoms
IUDs/Coils
Female condoms
Percent
 13 
 
METHOD CHOICE AMONG PVR USERS AND NONUSERS 
 
Ninety-five percent of the women chose the ring as the preferred method, while 5% chose it because their 
preferred method (progestin-only pills) was not available at the time of the visit. The most common reasons for 
choosing the ring as the preferred method were that it is user-controlled (49%); the perception that it did not 
have many side effects (46%); the perception that it was safe for breastfeeding (18%); perceived ease, comfort 
and convenience associated with the method (16%); and the desire to try a new method (14%) (Figure 2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Among women who were counseled on the ring but did not choose it and who agreed to be interviewed upon 
exit, the majority (47%) chose injectables, 34% chose progestin-only pills, 12% chose implants, 3% chose male 
condoms, 2% chose intrauterine contraceptive devices (IUDs), and another 2% opted to use the lactational 
amenorrhea method (LAM). The most commonly cited reason for choice of a particular method was that they 
had known it from before (39%) (see Figure 3). Other reasons (35%) included few or no side effects, 
convenience of use including secret use without partner’s knowledge, preference for long-term methods, and 
the desire to try another method. 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
FIGURE 2 REASONS FOR PVR CHOICE 
 
Note: Question allowed for multiple responses. Data source: Baseline 
dataset (N=57). 
 
FIGURE 3 REASONS FOR CHOOSING 
OTHER METHODS  
 
Data source: Nonuser dataset (N=58). 
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IMPRESSIONS ABOUT THE RING  
There were remarkable changes in participants’ perceptions about the ring between baseline and follow-up. 
For instance, half of the participants (50%) felt that the ring was too big at baseline, while at follow-up the 
majority of the women interviewed (93%) reported that the size of the ring was just fine (Table 4). Similarly, the 
proportion of participants who felt that the color of the ring was just fine increased from 78% at baseline to 
93% at follow-up. In addition, the proportion that felt that the texture of the ring was just fine increased from 
53% at baseline to 86% at endline (Table 4). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Further analysis showed that there were no significant differences in participants’ perceptions about the ring at 
baseline by whether they completed the two ring cycles. In particular, half of the 28 women who completed the 
two ring cycles and a similar proportion of those who discontinued use felt that the size of the ring was just 
fine, while 40%, or 4 women who were eventually lost to follow-up, felt that way. Similarly, the proportion of 
women who felt that the color of the ring was just fine was 81% among those who completed the two cycles, 
79% among those who discontinued use, and 70% among those lost to follow-up. The corresponding figures 
for those who felt that the texture of the ring was just fine were 58%, 54%, and 40% among the three groups of 
participants respectively. 
PERCEIVED QUALITY OF CARE 
Interviews with participants upon exit during recruitment showed that 85% of the respondents reported that 
providers had counseled them about breastfeeding requirements when using the ring (Table 5). Nearly all 
participants (97%) reported that providers counseled them on how and when to remove the ring, while all 
participants were given opportunity to ask questions. More than three-quarters (77%) of participants were 
encouraged to insert the ring themselves. All participants reported that they were shown how to insert the ring, 
while 73% reported that providers showed them how to remove the ring (Table 5). However, some providers 
reported that a few clients were reluctant to touch their own genitals and expected the providers to insert the 
ring for them just like they do with other methods requiring insertion, such as the IUD and implants.   
 
 
 
 
 
 
 
TABLE 4  Impressions about the ring 
Indicator Baseline, % (N=60) Follow-up, % (N=42) 
Impressions about size   
    Too small 1.7 0.0 
    Too big 50.0 7.1 
    Just fine 48.3 92.9 
Impressions about color   
    Too bright 21.7 7.1 
    Just fine 78.3 92.9 
Impressions about texture   
    Too soft 23.3 11.9 
    Too hard 23.3 2.4 
    Just fine 53.3 85.7 
Data source: Baseline and follow-up datasets. 
TABLE 5 Perceived quality of care 
Domain Item Response  (n)  Percent 
Counseling on 
the PVR 
method 
Provider conveyed minimum breastfeeding 
requirement 
Provider conveyed when to remove PVR 
Provider allowed respondent to ask questions 
Provider encouraged respondent to insert PVR 
Yes 
 
Yes 
Yes 
Yes 
 51 
 
58 
60 
46 
 85.0 
 
96.7 
100.0 
76.7 
Counseling on 
PVR use 
Provider showed how to insert PVR 
Provider showed how to remove PVR 
Yes 
Yes 
 60 
44 
 100.0 
73.3 
Data source: Baseline dataset. 
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ACCEPTABILITY 
 
Eighty-percent of participants who were interviewed upon follow-up reported that they were satisfied with the 
ring. The proportion reporting satisfaction with the ring was nearly twice as high among those who completed 
the two ring cycles (100%) than among those who terminated use (57%). Table 6 presents the distribution of 
participants who expressed satisfaction and dissatisfaction with the ring by experiences of using the method. A 
similar proportion of satisfied and dissatisfied participants found it easy to insert the ring (76% and 75%, 
respectively). However, a higher proportion of dissatisfied participants compared to their satisfied counterparts 
found it easy to remove the ring (75% and 51%, respectively) and to reinsert the ring (100% and 54%, 
respectively). None of the satisfied and dissatisfied clients reported experiencing side effects, which could 
imply that participants who terminated use because of side effects were not interviewed at follow-up. 
 
The results in Table 6 further show that a higher proportion of satisfied than dissatisfied participants did not 
experience expulsions (86% and 67%, respectively), did not feel the ring during sexual intercourse (89% and 
50%, respectively), did not report partners feeling the ring during sexual intercourse (63% and 25%, 
respectively), and indicated that their sexual pleasure increased during the time they were using the ring (34% 
and 25%, respectively). In addition, a higher proportion of satisfied than dissatisfied participants reported that 
they would use the ring in the future (92% and 50%, respectively), their partners and family members would 
support them in using the ring in the future (87% versus 0%, respectively), they would recommend the use of 
the ring to friends and family members (92% and 50%, respectively), they had already recommended the ring 
to family members or friends (73% and 50%, respectively), and that they would be willing to pay for the method 
(77% and 0%, respectively). Further analysis showed that those who reported willingness to pay for the method 
cited amounts ranging from KSh. 50 (~US$0.50) to KSh. 1,000 (~US$10) with a median of KSh. 200 (~US$2). 
 
  
TABLE 6 Responses by satisfaction related to PVR use 
Domain Item Response Satisfied Not Satisfied p Value  
Fisher’s Exact Test 
Ease of use Ease of inserting PVR 
Ease of removing PVR 
Ease of reinserting PVR 
Easy/Very easy 
Easy/Very easy 
Easy/Very easy 
75.7% 
51.4% 
54.1% 
75.0% 
75.0% 
100.0% 
0.82 
0.30 
0.08 
Side effects    Reported No 100.0% 100.0% — 
Expulsion PVR fell out on its own No 86.1% 66.7% 0.40 
Sexual intercourse 
 
Feel PVR during sex 
Partner feels PVR during sex 
Change in frequency of sex 
Change in sexual pleasure 
No 
No 
No change 
Increase 
    88.6% 
    62.9% 
    62.9% 
    34.3% 
      50.0% 
      25.0% 
      75.0% 
       25.0% 
0.00 
0.29 
0.18 
1.00 
Will use in future Interested  Yes     91.8%       50.0% 0.00 
Partner/family 
would support use 
Reported Yes     86.5%       0.0% 0.00 
Will recommend Reported Yes     91.9%       50.0% 0.03 
Already 
recommended 
Reported Yes 73.0%       50.0% 0.04 
Willingness to pay Interested  Yes     76.5%       0.0% 0.07 
Data source: Follow-up dataset. 
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Providers further reported that they received clients who were often referred by PVR users asking for the ring. 
They further reported that some of the participants who had completed the two ring cycles wanted another ring 
(which could not be provided outside the context of the study). Some of the participants also wanted a ring that 
could be used for one year or more.   
WOMEN PARTICIPANTS 
 
Satisfaction with the ring was also evident from the in-depth interviews with clients who were enrolled for 
qualitative interviews as exemplified by the excerpts in Table 7. 
 
TABLE 7 Responses by satisfaction related to PVR use 
Domain Comments 
Perceptions of  
PVR 
It’s easy to use it, especially compared to the pill. You don’t 
“forget” to take it, because it’s always there. (PVR User, Kiambu 
County) 
 It can be removed … that is one of the things that made me like 
it…. [If] I feel that it is not good for me, then I can remove it and 
shift to another [method]. (PVR User, Nairobi County) 
Partner’s feelings about PVR We were discussing this and he was saying that that is the best 
method because with the others I’ve had abdominal pain, 
bleeding, and so on. Also, when using the other methods, 
sometimes you feel like you don’t want to have sex, but with the 
ring I was very okay. (PVR User, Kiambu County) 
Sharing experiences with  
friends 
I told them it’s good. It’s stress-free and doesn’t have side-
effects, like headaches. (PVR User, Kiambu County) 
Data source: In-depth interviews with women. 
MALE PARTNERS  
Male partners of PVR users also found the ring acceptable and recommended a longer-lasting ring as shown by 
the quotes in Table 8. 
 
TABLE 8 Responses by satisfaction related to PVR use 
Domain Comments 
Perceptions of PVR 
 
 
 
 
Recommendations for  
the future 
I liked it. It didn’t interfere with breast-milk production or the 
sexual desire of my wife. I only wish that a long-acting PVR is 
introduced. That would help us a lot. (Partner of PVR User, 
Kiambu County) 
It’s very beneficial and user-friendly; it also does not interfere 
with the flow of breast milk. (Partner of PVR User, Nairobi 
County) 
The ring should be made as an annual one that should be 
removed after one year. (Partner of PVR User, Kiambu 
County) 
Data source: In-depth interviews with husbands. 
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PROVIDERS’ IMPRESSIONS 
 
Interviews with providers showed notable changes in their perceptions about the ring between baseline and 
endline. At endline, all providers reported that the ring was safe for postpartum women and for the infant and 
that they would recommend it to family members or friends (Table 9). In contrast, slightly more than half of the 
providers (57%) felt that the ring was safe for postpartum women and the infant at baseline, while less than 
9% indicated that they would recommend it to family members or friends. Similarly, nearly all providers (97%) 
at endline indicated that women in their locality would like the ring compared with just about half at baseline. A 
similar proportion of providers (97%) reported at endline that they would prescribe the ring to lactating women 
after the study ends.  
  
The results in Table 9 further show that there were notable changes between baseline and endline in the 
proportion of providers that reported that community health workers should be allowed to dispense the ring 
(from 17% to 67%), the ring does not affect sexual pleasure (from 51% to 83%), the ring does not interfere with 
sexual intercourse (from 57% to 93%), they would dispense the ring to lactating unmarried women with no 
contraindications (from 9% to 87%), and that they would not require the husband’s consent before dispensing 
the ring (from 9% to 83%). In addition, most of the providers (93%) reported at endline that they did not receive 
any complaints from husbands/partners of study participants regarding the use of the ring, while about half 
(53%) reported that they did not receive any complaints from users. The smallest increase was in the 
proportion of providers who felt that the ring does not increase risk of vaginal or pelvic infections (from 37% at 
baseline to 57% at endline).   
 
TABLE 9 Providers’ responses by satisfaction related to PVR use 
Domain Baseline 
(N=35) 
Endline 
(N=30) 
PVR is safe for postpartum women 57.1% 100.0% 
PVR is safe for baby 57.1%  100.0% 
PVR does not increase risk of vaginal/pelvic infections 37.1%    56.7% 
Lactating women in the locality would like PVR 54.3%   96.7% 
Community health workers should be allowed to dispense PVR 17.1%   66.7% 
PVR does not affect sexual pleasure 51.4%   83.3% 
PVR does not interfere with sexual intercourse 57.1%   93.3% 
Would recommend PVR to family members/friends 8.6% 100.0% 
Would provide PVR to unmarried women with no contraindications 8.6%   86.7% 
Would not require husband’s consent before dispensing PVR 8.6%   83.3% 
Did not receive any complaints from clients regarding PVR use —   53.3% 
Did not receive any complaints from spouses/partners regarding PVR 
use 
—   93.3% 
Would prescribe PVR to lactating women after the study ends —   96.7% 
Data source: Provider interviews at baseline and endline. 
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COMMUNITY STAKEHOLDERS  
 
Findings from focus group discussions with community stakeholders showed that the ring was acceptable for 
various reasons, including convenience and ease of use, as shown by the quotes in Table 10. 
 
TABLE 10 Responses by satisfaction related to community members’ PVR use 
Domain Comments 
Perceptions of PVR 
[The PVR] is the best way since it will not cause any problems even if 
breastfeeding. Breastfeeding women can sometimes get pregnant before 6 
months and that is a problem for men since they will be denied sex with 
women. (Community Leaders, Kiambu County) 
 
[The PVR] will be considered easy and cheap to use. Women have a lot of 
issues: You will find that your husband was out on a trip, comes back 
abruptly, and wants to leave just as quickly. Then you realize that you 
haven’t taken your pill and he wants to have sex. Do you think you’ll tell him 
to wait until you take the pill first when you’ve probably been hiding it from 
him? Definitely not. So, to avoid such awkward moments, I would rather use 
the vaginal ring to be safe at all times. (Community Leaders, Nairobi County) 
Data source: Focus-group discussion. 
 
PARTNERS’ SUPPORT AND EXPERIENCE 
 
Half of the participants who were interviewed 
during follow-up and who reported that they had 
resumed sexual intercourse indicated that their 
partners felt the ring (Figure 4). Slightly more 
than one-third (36%) indicated that the ring 
negatively affected their partners’ sexual 
pleasure, with 41% indicating that the partners’ 
sexual pleasure increased. Further analysis 
showed that a higher proportion of participants 
who completed the two ring cycles, compared 
with those who terminated use, reported that 
their partners felt the ring during sexual 
intercourse (52% and 47%, respectively); that the 
ring affected their partners’ sexual pleasure (40% 
and 32%, respectively); and that their partners’ 
sexual pleasure increased (56% and 21%, respectively).   
 
Increase in partners’ sexual experience was further reflected in the in-depth interviews. As one user who was 
enrolled for in-depth interviews put it: 
I can tell women [that] if they use [the ring], even their husbands will say, “Ah! ... the act in bed … they 
[men] say it’s good … He says it’s because of the ring. (In-depth interview, Kiambu County)   
 
Field reports also showed that a few participants were accompanied by their spouses who helped in decision-
making regarding the choice of the ring. In one case, a participant who had completed the two ring cycles and 
switched to another method was told by the husband to return to the facility and take up another ring. 
However, there were also a few participants who after being counseled, reported that they had to consult their 
husbands before they could take up the ring. In addition, as already noted, one client discontinued use 
because she reported that her husband was not comfortable with the ring. 
 
FIGURE 4 PARTNERS’ REACTIONS ON 
PVR USE 
 
Data source: Follow-up dataset (N=44). 
50.0
36.4
40.9
0 20 40 60
Partner felt the ring during sex
Ring negatively affected
partners' sexual pleasure
Partners' sexual pleasure
increased
Percent
 19 
 
DISCONTINUATION 
 
Twenty-six of the 60 participants (43%) who enrolled for follow-up completed two ring cycles, 24 (40%) 
discontinued use for various reasons (Figure 4), while 10 (17%) were lost to follow-up. Table 11 presents the 
distribution of participants who completed the two ring cycles and those who terminated use by experiences 
with the ring. The proportion of participants who found the ring easy to insert was higher among those who 
completed the two ring cycles than among those who terminated use (77% and 63%, respectively). In contrast, 
the proportion of participants who found the ring easy to remove was higher among those who terminated use 
than among those who completed the two ring cycles (54% and 46%, respectively). Similarly, all women who 
completed the two ring cycles did not experience expulsion. The proportion that did not experience expulsion 
was much lower among those who terminated use (68%).    
 
The results in Table 11 further show that the proportion of participants who did not feel the ring during sex was 
higher among those who completed the two ring cycles than among those who terminated use (92% and 58%, 
respectively). Similar differences between those who completed two ring cycles and those who terminated use 
were noted in the proportion of participants whose partners did not feel the ring during sex (76% and 32%, 
respectively) as well as those who did not experience any change or experienced an increase in the frequency 
of sex (96% and 84%, respectively) or sexual pleasure (96% and 74%, respectively).  
 
 
The most common reason for 
discontinuing use of the ring was 
expulsion (Figure 5). Another 10 
participants were lost to follow-up having 
moved out of the study setting or due to 
incorrect contact information, while 5 
discontinued use because they reported 
experiencing side effects including 
abdominal pain, vaginal bleeding, and 
loss of libido. Three participants were 
discontinued due to non-adherence to 
study procedures, because they left the 
ring out for more than two hours. One 
participant stopped use because she 
associated the illness of one of her twin 
babies to the use of the ring (i.e., 
misconception about the method). 
TABLE 11  Responses by continuation related to PVR use 
Domain Item Response Continued 
  (N=26) 
Terminated 
(N=24) 
P Value  
Fisher’s Exact Test 
Ease of use Ease of inserting PVR 
Ease of removing PVR 
Ease of reinserting PVR 
 Easy/Very easy 
 Easy/Very easy 
 Easy/Very easy 
76.9% 
46.2% 
53.9% 
62.5% 
54.2% 
54.2% 
0.36 
0.78 
1.00 
Expulsion PVR fell out on its own 
Frequency of feeling the PVR  
No 
No, never 
100.0% 
68.0% 
68.4% 
52.6% 
0.00 
0.36 
Sexual 
intercourse 
Feel PVR during sex 
Partner feels PVR during sex 
Removal during sex 
Change in frequency of sex 
Change in sexual pleasure 
No 
No 
No 
No change or increase 
No change or increase  
92.0% 
76.0% 
100.0% 
96.0% 
96.0% 
57.9% 
31.6% 
94.7% 
84.2% 
73.7% 
0.01 
0.01 
0.43 
0.30 
0.07 
Data source: Baseline and follow-up datasets. 
 
FIGURE 5 REASONS FOR DISCONTINUING PVR 
 
Data source: Follow-up dataset (N=34). 
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Figure 6 presents the distribution of participants 
who completed the two ring cycles and those who 
terminated participation but were interviewed at 
follow-up by type of method they switched to. The 
proportion of participants who switched to 
injectables was higher among those who 
terminated use than among those who completed 
the two ring cycles (72% and 6%, respectively). In 
contrast, the proportion of participants who 
switched to implants was higher among those who 
completed the two ring cycles than among those 
who terminated use (56% and 17%, respectively). 
Similar variations were noted with respect to 
switching to the IUD (25% among those who 
completed the two ring cycles compared with 6% 
among those who terminated use). 
 
Further analysis showed that the proportion of participants who had ever used injectables was almost similar 
among those who completed the two ring cycles and those who terminated use (40% and 38%, respectively). 
However, a higher proportion of participants who completed the two ring cycles had ever used pills compared 
with those who terminated use (67% and 38%, respectively). A similar pattern was noted for the IUD, with 13% 
of those who completed the two cycles having previously used the method compared with none among those 
who terminated use. In contrast, the proportion that had ever used implants was nearly twice as high among 
those who terminated use compared with those who completed the two cycles (13% and 7%). 
ADVERSE AND SERIOUS ADVERSE EVENTS 
 
Tables 12 and 13 list the adverse and serious 
adverse events that occurred in the course of the 
study. There were a total of three adverse events and 
one serious adverse event. The first adverse event 
was a mild urinary tract infection, which was treated. 
The provider determined the relationship of the 
condition with the product as “possible.” However, 
the participant continued using the ring and 
completed the two ring cycles. 
  
The second adverse event involved complaints about 
lower abdominal pains, which the provider 
determined did not require treatment but was 
possibly related to the study product. The participant 
also reported that her husband had told her to 
remove the ring as a result. Her participation in the 
study was therefore terminated.  
 
The third adverse event involved prolonged bleeding, which the provider determined was possibly related to the 
study product. The participant sought treatment from a nonparticipating facility where she was advised to remove 
the ring. The provider therefore decided to terminate her participation in the study. The condition for the serious 
adverse event could not be conclusively determined because the participant sought care from a nonparticipating 
facility. The case was, however, considered a serious adverse event because the participant was hospitalized 
while still in the study. The study team realized that there was a serious adverse event when the client failed to 
return for a scheduled visit and attempted to follow up. However, the provider indicated that the condition was 
severe headache and psychosis based on the report of the mother-in-law and that it was unlikely related to the 
study product. The information was shared with the Population Council’s Safety Desk for determination as well. 
The Safety Desk then developed a report, which was shared with the local regulatory authorities.  
 
FIGURE 6 METHOD SWITCH 
 
Data source: Follow-up dataset (N=43). 
TABLE 12  Adverse events 
Number Description Treatment 
KE14104 
KE14108 
KE16101 
Mild urinary tract infection 
Lower abdominal pain 
Prolonged bleeding 
Treated and discharged 
No treatment required 
Treated and discharged 
Data source: Case record forms.  
   
   
TABLE 13  Serious adverse events 
Number Description Treatment 
KE16102 Severe headache 
and psychosis 
Treated in a 
nonparticipating facility 
Data source: Case record forms. 
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Discussion 
ACCEPTABILITY  
 
A number of key findings emerged from this study that will be useful for future introduction efforts. Most 
importantly, the ring was acceptable to most users, partners, providers, and other community members. The 
majority of participants who completed the two ring cycles indicated that they would use the ring in the future, 
their partners or family members would support future use, they would recommend or had already 
recommended the ring to their friends or family members, and that they were willing to pay for the method. In 
addition, some clients were encouraged by their spouses to use the ring. There were also remarkable positive 
changes between baseline and follow-up in the perceptions of participants and providers about the ring. These 
are indications that the ring was acceptable to clients and key stakeholders. Acceptability of the ring to clients 
and key stakeholders is, in turn, important for informing the introduction of the method into the country. 
 
Several attributes associated with the ring are likely to contribute to increased uptake of the method. The most 
commonly cited reason for the choice of the ring among users was that the method is user-controlled. Most 
users also found the ring easy to insert, remove, and reinsert. Such attributes are likely to increase the uptake 
of the method in the country. This is also consistent with findings from studies in other settings such as 
Australia, Canada, Chile, the Dominican Republic, and the United States that found that women liked vaginal 
rings for the same reasons (RHSC 2011). 
 
In addition, the majority of users were young, educated, urban or peri-urban dwellers. The majority of women 
who chose the ring were aged 20–29 years, had at least secondary level education, and resided in urban or 
peri-urban areas. In addition, the majority of PVR users had given birth to at least two children and wanted to 
space the next birth by at least four years. These findings are consistent with those of market segmentation 
analysis of existing Demographic and Health Survey data using a needs-based approach, which showed that 
most users of the ring are likely to have these attributes (Obare et al. 2014). The findings suggest that these 
categories of clients are likely to be the first acceptors of the method if it is introduced into the country before 
usage diffuses to other segments of the population.  
 
Next, the PVR is likely to expand contraceptive choices during the postpartum period. The second major reason 
for choosing the ring was the perception of fewer side effects. In addition, some clients chose the ring just to 
try a new method, while others chose it because their preferred method was not available at the time of the 
visit. Given that the postpartum period is characterized by high unmet need for contraception and a limited 
range of available methods, expanding contraceptive choices for postpartum women has been a key priority of 
the Ministry of Health (DRH 2010; KNBS and ICF Macro 2010).  
 
Expanding method choices is likely to sustain or to contribute to an increased contraceptive prevalence rate. 
Slightly more than one-third of PVR users were new family planning users. The goal of the Ministry of Health 
was to achieve a contraceptive prevalence rate of 56% by 2015. Findings from the 2014 KDHS showed that 
the prevalence rate had increased to 58% from 46% in 2008–09 (KNBS and ICF Macro 2010; KNBS et al. 
2015). By drawing in new users, the ring is likely to sustain the prevailing contraceptive prevalence rate or 
contribute to a further increase provided efforts are put in place to support users and providers and to reduce 
discontinuation.  
 
Finally, the PVR is likely to bridge users to long-term methods, especially those involving insertion. The findings 
of the study showed that those who completed two ring cycles were more likely to switch to implants or IUDs 
compared with those who terminated use. Switching to long-term methods was also consistent with the finding 
that most users wished to space the next pregnancy by at least four years. The finding further suggests that 
the ring is likely to contribute to increased uptake of methods involving insertion and trained providers.    
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LIMITATIONS 
 
The above findings could be influenced by the following study limitations. The target sample size of 58 clients 
for follow-up was small. However, as already noted, the sample size was powered to detect significant 
differences for the three countries combined (Kenya, Nigeria, and Senegal) with 58 clients targeted in each 
country. Given that the study involved prospective follow-up of clients, it was affected by loss to follow-up 
mostly occasioned by participants moving out of the study area or providing incorrect contact information. 
However, the rate of loss to follow-up (17%) was within the recommended minimum of between 20% and 30% 
for cohort studies (Babbie 1973; Altman 2000). Finally, discontinuation was mainly due to experiences of ring 
expulsion followed by side effects and non-adherence to use procedures. Ring expulsion and non-adherence to 
use procedures were found to be the second most common reasons for termination of ring use in other studies 
(Diaz et al. 1997; Sivin et al. 1997; Massai et al. 1999, 2005). The rate of discontinuation of ring use in the 
study (40%) was also comparable to, or lower than, that of other methods in the country. For instance, 
estimates from 2008–09 KDHS show that the rate of discontinuation was 29% for injectables, 43% for pills, 
59% for condoms, and 36% for all methods (KNBS and ICF Macro 2010).  
LESSONS LEARNED FOR FUTURE INTRODUCTION OF RINGS 
 
The findings of the study have the following implications for future efforts geared toward introducing the ring in 
the country: 
 
 Client counseling on proper use of the ring: Given that the ring is a user-controlled method, service delivery 
programs should consider ways of ensuring that clients obtain information on correct use including proper 
insertion and adherence to use instructions, such as not leaving the ring out for long. Proper insertion and 
adhering to use instructions are, in turn, likely to reduce instances of ring expulsion and discontinuation.  
 
 Addressing misconceptions: Just like any other family planning method, programs delivering the ring need 
to consider addressing misconceptions about the method. This was evident from the finding that one client 
terminated use because she associated the illness of one of her twins with the use of the ring. In addition, 
it is likely that those who terminated use because of the influence of mothers-in-law or spouses could 
partly be due to misconceptions about the method on the part of these significant others.   
 
 Mechanisms for bridging users to long-term methods: It was evident that those who completed the two 
ring cycles mostly switched to long-term methods at the end of the study. In addition, most users desired 
longer birth spacing. Programs delivering the ring therefore need to consider mechanisms for bridging 
users to long-term methods. 
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Appendix 
APPENDIX A1: INCLUSION/EXCLUSION CRITERIA  
A. INCLUSION CRITERIA 
To participate in the study, a woman had to meet all the inclusion criteria listed below at enrollment: 
1. Able to provide informed consent 
2. Age 18 to 35 years (inclusive) 
3. Delivered a healthy singleton infant 6 to 9 weeks prior to study enrollment 
4. Has at least (1) living child and is fully/nearly fully breastfeeding the new infant  
5. Willing to continue breastfeeding infant a minimum of 4 times per day for at least 6 months. 
6. Is in good health as confirmed by medical history, physical examination. (Includes vital signs and 
diagnosis/treatment of vaginal infection per the standard of care in Kenya. Treatment of vaginal infection 
is required prior to enrollment.) 
7. Has or expects to have regular exposure to the risk of pregnancy 
8. Willing to choose the PVR as contraceptive method 
9. Willing and able to follow study procedures  
10. Expects to continue living in an area accessible to the study site for the duration of the study. 
B. EXCLUSION CRITERIA 
Similarly, women with any of the following attributes were excluded from participating in the study: 
1. Is pregnant or suspected of being pregnant 
2. Breastfeeding less than fully/nearly fully 
3. Hypersensitivity to hormonal preparations or silicone rubber 
4. HIV positive or in a discordant relationship 
5. Presence of genital or urinary tract infection 
6. Dyspareunia 
7. History of Human Papillomavirus (HPV) 
8. History of bacterial infections such as Chlamydia and gonorrhea 
9. History of pelvic inflammatory disease (PID) or salpingitis since delivery 
10. History of chronic constipation 
11. Clinically relevant genital prolapse  
12. Has history of generalized urticaria 
13. Any chronic condition requiring continuous or regular use of medication or herbals prescribed by healers 
14. Has a history of thrombophlebitis or thromboembolism  
15. History of and/or current depression 
16. History of epilepsy or convulsive disorder  
17. Had an ectopic pregnancy 
18. Has vaginal bleeding not attributable to menses 
19. Known or suspected carcinoma of the breast 
20. Has had any other known or suspected neoplasia within last 5 years 
21. Not exposed to risk of pregnancy 
22. Use of chronic medications, Rifampicin, Griseofluvin, barbiturates, phenytoin, ketoconozole, butazoliden  
23. Confirmed hypertension (blood pressure—systolic more than 140 mmHg and/or diastolic more than 90 
mmHg) 
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